Cytokine Storm Market Report 2025 (Global Edition)

Global Cytokine Storm Market Report 2025 Market Size Split by Type (Oral, Intravenously), by Application (Hospitals, Homecare, Specialty Clinics, Others), by Markers (EGF, G-CSF, GM-CSF, GRO-alpha, IF...

Cytokine Storm Market Report Description

We have various report editions of Cytokine Storm Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Cytokine Storm Market Insights Video

Competitive Landscape of the Cytokine Storm Market

The Cytokine Storm Market is characterized by intense competition among a diverse range of players, including established pharmaceutical companies, emerging biotechs, and academic research institutions. Key players such as Roche, Novartis, and Sanofi dominate the market with their extensive portfolios of immunomodulatory therapies and significant investments in R&D. These companies leverage their strong financial resources and global distribution networks to maintain market leadership.

July 2022:Sandoz, a global leader in generic and biosimilar medicines, announced that the US Food and Drug Administration (FDA) has accepted for review its Supplemental Biologics License Application (sBLA) for a high concentration formulation of 100 mg/mL (HCF) of its biosimilarHyrimoz (adalimumab-adaz). (Source:https://www.sandoz.com/sandoz-supplemental-biologics-license-application-accepted-us-fda-biosimilar-hyrimozr-adalimumab/) March 2022:Xenco, a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases presented preclinical data from XmAb Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022. (Source:https://investors.xencor.com/news-releases/news-release-details/xencor-presents-preclinical-data-multiple-xmabr-research)

Top Companies Market Share in Cytokine Storm Industry: (In no particular order of Rank)

• Roche
• Incyte Corporation
• Jazz pharmaceuticals
• Novartis
• CytoSorbents
• Swedish Orphan Biovitrum (Sobi)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cytokine Storm Market

Which Region Dominates the Cytokine Storm Market in 2024?

According to Cognitive Market Research, North America is the dominant region in the Cytokine Storm Market due to its advanced healthcare infrastructure, substantial investment in research and development, and the presence of major pharmaceutical and biotechnology companies. The region's high prevalence of autoimmune diseases and inflammatory conditions drives the demand for effective cytokine storm therapies. Additionally, strong government support for healthcare initiatives, favorable reimbursement policies, and a well-established regulatory framework further bolster market growth.

Which Region is Expanding at the Fastest CAGR?

Asia Pacificis the fastest-growing region in the cytokine storm market due to several key factors. The region is experiencing rapid advancements in healthcare infrastructure and a rising prevalence of chronic diseases, which contribute to an increased focus on immunotherapy and cytokine storm management. Additionally, significant investments in medical research and development, coupled with growing healthcare expenditures, are accelerating market growth. The expanding biotechnology sector and supportive government policies in countries like China and India further drive innovation and adoption of new treatments, making Asia Pacific a hotbed for growth in the cytokine storm market.

 

The current report Scope analyzes Cytokine Storm Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Cytokine Storm Market Analysis

According to Cognitive Market Research, the global Cytokine Storm market size was estimated at USD XX Million,out of which North America held the major market of more than 40% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2%from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cytokine Storm market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The demand is amplified by the nation's advancements in healthcare infrastructure and heightened awareness of inflammatory diseases.
• The Canada Cytokine Storm market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Canada's advancements in healthcare infrastructure and heightened awareness of inflammatory diseasesto increased usage of Cytokine Storm.
• The Mexico Cytokine Storm market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD XX million in 2024.

Europe Cytokine Storm Market Analysis

According to Cognitive Market Research, the global Cytokine Storm market size was estimated at USD XX Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5%from 2024 to 2031.

• The United Kingdom Cytokine Storm market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. In the UK, Cytokine Storm sales witness an upswing due to the nation's increased research and development activities and the growing prevalence of cytokine storm-related conditions.
• The France Cytokine Storm market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 247.05 million in 2024.
• According to Cognitive Market Research, the Germany Cytokine Storm market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. In Germany, Cytokine Storm sales surged due to the increased research and development activities and the growing prevalence of cytokine storm-related conditions.
• The Italy Cytokine Storm market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD XX million in 2024.
• The Russia Cytokine Storm market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD XX million in 2024.
• The Spain Cytokine Storm market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD XX million in 2024
• The LuxembourgCytokine Storm market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD XX million in 2024.
• The PortugalCytokine Storm market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD XX million in 2024.
• The GreeceCytokine Storm market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD XX million in 2024.
• Rest of Europe'sCytokine Storm market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD XX million in 2024.

Asia Pacific Cytokine Storm Market Analysis

According to Cognitive Market Research, the global Cytokine Storm market size was estimated at USD XXMillion, out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0%from 2024 to 2031.

• According to Cognitive Market Research, the China Cytokine Storm market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Cytokine Storm sales surge in China due to the increasing investment in advanced treatment options.
• The Japan Cytokine Storm market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD XX million in 2024.
• The India Cytokine Storm market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. India's increasing investment in advanced treatment options.
• The South Korea Cytokine Storm market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD XX million in 2024.
• The Australia Cytokine Storm market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.
• The South East Asia Cytokine Storm market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Asia Pacific Cytokine Storm market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.

South America Cytokine Storm Market Analysis

According to Cognitive Market Research, the global Cytokine Storm market size was estimated at USD XX Million out of which Latin America market of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4%from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Cytokine Storm market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Cytokine Storm sales flourish in Brazil due to the expanding healthcare infrastructure.
• Argentina Cytokine Storm market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina's expanding healthcare infrastructure.
• Colombia Cytokine Storm market is projected to witness growth at a CAGR of 4.2% during the forecast period with a market size of USD XX million in 2024.
• Peru Cytokine Storm market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD XX million in 2024.
• Chile Cytokine Storm market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Latin America Cytokine Storm market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD XX million in 2024.

Middle East Cytokine Storm Market Analysis

According to Cognitive Market Research,the global Cytokine Storm market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7%from 2024 to 2031.

• The GCC Countries Cytokine Storm market is projected to witness growth at a CAGR of 5.5% during the forecast period with a market size of USD XX million in 2024. Cytokine Storm sales flourish due to the improvements in healthcare infrastructure and an increasing focus on specialized medical treatments.
• The Egypt Cytokine Storm market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD XX million in 2024.
• The South Africa Cytokine Storm market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD XX million in 2024. Cytokine Storm sales flourish in South Africa due to the improvements in healthcare infrastructure and an increasing focus on specialized medical treatments.
• The Turkey Cytokine Storm market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD XX million in 2024.
• The Nigeria Cytokine Storm market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of MEA Cytokine Storm market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD XX million in 2024.

Cytokine Storm Market Analysis

Cytokine StormMarketTypeSegment Analysis

According to Cognitive Market Research, Intravenously administration of treatments holds the dominant position due to its rapid and efficient delivery of therapeutic agents directly into the bloodstream. This method ensures that the medication quickly reaches systemic circulation, which is crucial in managing severe cytokine storms where immediate intervention is necessary to mitigate systemic inflammation and prevent organ damage. The intravenous route is particularly favored in acute settings, such as hospital emergency rooms and intensive care units, where the severity of cytokine storms demands swift and effective treatment.

The oral administration of cytokine storm treatments is emerging as the fastest-growing category in the market. This growth is driven by the increasing demand for patient-friendly, at-home treatment options that offer convenience and ease of use compared to intravenous therapies. Oral medications are generally more accessible and have the potential to improve patient compliance by eliminating the need for frequent hospital visits or infusions. Advances in drug formulation and delivery technologies are enhancing the effectiveness and absorption of oral treatments, making them a promising alternative for long-term management of cytokine storms.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cytokine Storm Industry. Request a Free Sample PDF!

Cytokine Storm Market Application Segment Analysis

According to Cognitive Market Research, hospitals are the dominant application category due to their critical role in providing intensive care for severe cases. Hospitals are equipped with advanced medical technologies and specialized personnel trained to manage complex cytokine storm conditions effectively. The presence of on-site diagnostic facilities and emergency response teams allows for rapid intervention and monitoring, which is crucial for addressing the life-threatening complications associated with cytokine storms. Additionally, hospitals often have access to a wide range of treatment options, including intravenous therapies and cutting-edge medical interventions, further solidifying their dominant position in the market.

The Homecare is emerging as the fastest-growing application category in the cytokine storm market. This growth is fueled by the increasing shift towards patient-centered care and the need for more flexible treatment options that allow patients to manage their condition in the comfort of their own homes. Advances in telemedicine and home-based monitoring technologies are enabling patients to receive effective care while reducing the strain on hospital resources. The development of oral and self-administered therapies tailored for home use is driving this trend, as they offer a convenient alternative to frequent hospital visits.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Cytokine Storm Markers Segment Analysis

Markers Segment Analysis

According to Cognitive Market Research, the IL-6 is the dominant marker due to its significant role in the inflammatory response associated with severe cytokine storms. IL-6 is a key pro-inflammatory cytokine that is elevated in many acute and chronic inflammatory conditions, making it a critical target for both diagnosis and therapeutic intervention. Its prominence is evident in various clinical studies and treatment protocols aimed at controlling hyperinflammation. The development of IL-6 inhibitors, such as tocilizumab, further underscores its importance in managing cytokine storm conditions, solidifying its position as the leading marker in this market.

The IL-33 is emerging as the fastest-growing marker in the cytokine storm market. Recent research has highlighted IL-33's role in driving inflammation and immune responses in cytokine storms, leading to increased interest in its potential as a therapeutic target. The growing understanding of IL-33’s involvement in various inflammatory diseases and its unique mechanism of action is accelerating the development of diagnostic and treatment options related to this marker. As research progresses and more therapies targeting IL-33 are introduced, its significance in managing cytokine storms is expected to rise, contributing to its rapid growth in the market.

• EGF
• G-CSF
• GM-CSF
• GRO-alpha
• IFN-alpha
• IFN-gamma
• IL-1 Beta
• IL-1RA
• IL-2
• IL-5
• IL-6
• IL-8
• IL-10
• IL-13
• IL-17a
• IL-18
• IL-33
• IP-10
• MCP-1
• MIP-1
• TNF-alpha

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion